EVGN:NASDAQ
Evogene Ltd
0,39 US$
arrow_upward
+1,13%(+0,0043) 1 d
0,38 US$
arrow_downward
−1,99% (−0,0077)bedtimeEfter stängning
Stängd: 12 okt., 16:00:02 GMT−4 · USD
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för EVGN …
Öppen
0,39 US$
Högt
0,40 US$
Lågt
0,38 US$
Börsvärde
7,02 mn
Genomsn. vol.
2,57 mn
Volym
0,00
52v högst
1,49 US$
52v lägst
0,35 US$
EPS
−0,90 US$
Beta
1,44
Utestående aktier
18,05 mn
Antal anställda
52
Öppen
0,39 US$
Högt
0,40 US$
Lågt
0,38 US$
Börsvärde
7,02 mn
Genomsn. vol.
2,57 mn
Volym
0,00
52v högst
1,49 US$
52v lägst
0,35 US$
EPS
−0,90 US$
Beta
1,44
Utestående aktier
18,05 mn
Antal anställda
52
Nyheter och artiklar
Från webbkällor och nyhetspartner
Investing.com Nigeria
·
för 1 dag sedan
Form 13D/A Evogene Ltd. For: 11 October By Investing.com
Profil
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Om Evogene Ltd